Atlantic Edge Private Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Atlantic Edge Private Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500	Closed	-$4.41K	–	585
2025 Q3	$4.41K	Hold	500	–	–	﹤0.01%	449
2025 Q2	$3.19K	Hold	500	–	–	﹤0.01%	451
2025 Q1	$2.43K	Hold	500	–	–	﹤0.01%	450
2024 Q4	$4.78K	Hold	500	–	–	﹤0.01%	394
2024 Q3	$4.17K	Hold	500	–	–	﹤0.01%	415
2024 Q2	$3.41K	Hold	500	–	–	﹤0.01%	402
2024 Q1	$1.26K	Hold	500	–	–	﹤0.01%	451
2023 Q4	$1.2K	Buy	+500	New	+$1.18K	﹤0.01%	434

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atlantic Edge Private Wealth Management's EBS Position: Q4 2025 in Review

Atlantic Edge Private Wealth Management sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 500 shares — an estimated $4.41K sold.

Atlantic Edge Private Wealth Management first reported a position in EBS in Q4 2023 and held it in 8 quarters. The position peaked at $4.78K in Q4 2024. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

Atlantic Edge Private Wealth Management reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
Atlantic Edge Private Wealth Management sold 500 Emergent Biosolutions shares in Q4 2025, an estimated $4.41K.
Atlantic Edge Private Wealth Management first reported a position in Emergent Biosolutions in Q4 2023 and held it in 8 quarters.
Atlantic Edge Private Wealth Management's Emergent Biosolutions position peaked at $4.78K in Q4 2024.
183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q4 2025, filed 27 Jan 2026.